Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Pharma Data | Q&As & Interviews

In Conversation With Dr. Maya Natarajan, Neo4J

14 December 2022
In the lead up to our 2022 Pharma Data & SmartLabs Congress taking place this September, we sat down with Maya Natarajan, Senior Director Knowledge Graphs at Neo4j. Being a key player within the field, Maya gave us insights into the pioneering work Neo4j is doing with knowledge graphs and the types of graph analytics that Neo4J provides.
https://youtu.be/NV5uEaE8ThA

Speaker Biographies

Dr. Maya Natarajan is Senior Director of Knowledge Graphs at Neo4j. She is passionate about bringing different technologies together to solve complex problems. At Neo4j, Maya is championing the use of knowledge graphs to bring context to various systems. Maya has positioned technologies from blockchain to predictive and user-based analytics, to machine learning, to deep learning, to search, to BPM, and beyond in a myriad of industries at various small and large companies. Maya started her career in biotechnology where she was in R&D focusing on cardiovascular drugs, and she has five patents to her name.

 

Related Resources

Funding Opportunity Announced for Generating Real-World Evidence in Regulatory Decision-Making

The U.S. Food and Drug Administration (FDA) is encouraging pharmaceutical developers to submit real-world evidence in support of regulatory applications.
Read More

The Evolution of Pharma Data Practices

Pharma data practices have evolved with the times. Today, approaches such as AI and machine learning afford the opportunity to enhance drug development and safety, culminating in AI-driven insights that promise better patient outcomes.
Read More